Joanna Gibson, MD, PhD
Associate Professor of Pathology; Director of Quality and Patient Safety, Pathology
Research & Publications
Biography
News
Locations
Research Summary
My research efforts are primarily aimed at clinical diagnosis and best practices in the field of neoplasia involving the tubal gut. I am interested in answering questions that arise during clinical practice, in order to provide evidence-based data that impacts patient diagnosis, triage and follow up care. This includes a variety of approaches, including recognition and characterization of novel diagnostic entities, refining assessment of morphologic features and other clinical tools for the correct diagnosis, and development of diagnostic guidelines for best clinical practice.
Coauthors
Selected Publications
- Systems approach to enhance Lynch syndrome diagnosis through tumour testingSingh V, Mezzacappa C, Gershkovich P, Di Giovanna J, Ganzak A, Gibson J, Sinard J, Xicola RM, Llor X. Systems approach to enhance Lynch syndrome diagnosis through tumour testing. Journal Of Medical Genetics 2022, 60: 533-539. PMID: 36115663, PMCID: PMC10020126, DOI: 10.1136/jmg-2022-108770.
- Tu1100: HETEROZYGOUS MUTATIONS IN DNA REPAIR GENES CONFER GENETIC SUSCEPTIILITY TO COLORECTAL CANCER AMONG LYNCH-LIKE CASESGiner-Calabuig M, De Leon S, Vidal-Pedrola G, Fehlmann T, Ukaegbu C, Gibson J, Picó M, Alenda C, Reyes J, Ortega S, LLado C, de la Torre Rubio P, Obrador-Hevia A, Castillejo A, Soto J, Castellví-Bel S, Syngal S, Stoffel E, Ellis N, Jover R, Llor X, Xicola R. Tu1100: HETEROZYGOUS MUTATIONS IN DNA REPAIR GENES CONFER GENETIC SUSCEPTIILITY TO COLORECTAL CANCER AMONG LYNCH-LIKE CASES. Gastroenterology 2022, 162: s-883. DOI: 10.1016/s0016-5085(22)62088-2.
- QIM22-192: Mismatch Repair Protein Immunohistochemistry: Quality of Mismatch Repair Deficiency DetectionMatsumoto N, Barbieri A, Gershkovich P, Cecchini M, Gibson J. QIM22-192: Mismatch Repair Protein Immunohistochemistry: Quality of Mismatch Repair Deficiency Detection. Journal Of The National Comprehensive Cancer Network 2022, 20: qim22-192. DOI: 10.6004/jnccn.2021.7192.
- Abstract PO-052: A multisystem approach doubles the number of patients referred for genetic testing and diagnosed with Lynch syndrome with equally success among ethnic/racial groupsSingh V, Ganzak A, Gershkovich P, Gibson J, Xicola R, Llor X. Abstract PO-052: A multisystem approach doubles the number of patients referred for genetic testing and diagnosed with Lynch syndrome with equally success among ethnic/racial groups. Cancer Epidemiology Biomarkers & Prevention 2022, 31: po-052-po-052. DOI: 10.1158/1538-7755.disp21-po-052.
- Pathogenic BRCA2 germline variants in combined hepatocellular‐cholangiocarcinomaLi H, Zhang X, Finberg KE, Walther Z, Jain D, Gibson J. Pathogenic BRCA2 germline variants in combined hepatocellular‐cholangiocarcinoma. Pathology International 2021, 72: 138-140. PMID: 34808016, DOI: 10.1111/pin.13188.
- Su076 COST-EFFECTIVENESS ANALYSIS OF SCREENING STRATEGIES FOR LYNCH SYNDROME UNDER DIFFERENT SYSTEMS APPROACHESZhu J, Singh V, Gershkovich P, Ganzak A, Gibson J, Yaesoubi R, Llor X. Su076 COST-EFFECTIVENESS ANALYSIS OF SCREENING STRATEGIES FOR LYNCH SYNDROME UNDER DIFFERENT SYSTEMS APPROACHES. Gastroenterology 2021, 160: s-606-s-607. DOI: 10.1016/s0016-5085(21)02152-1.
- Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment planGibson JA, Finberg KE, Nalbantoglu I, Cecchini M, Ganzak A, Walther Z, Sklar JL, Eder JP, Goldberg SB. Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan. The Lancet Oncology 2021, 22: 306-307. PMID: 33662283, DOI: 10.1016/s1470-2045(20)30683-5.
- 1 IMPROVING LYNCH SYNDROME IDENTIFICATION THROUGH THE IMPLEMENTATION OF ENHANCED TUMOR TESTING AND A COMPREHENSIVE SYSTEMS APPROACHSingh V, Ganzak A, Gershkovich P, Gibson J, Llor X. 1 IMPROVING LYNCH SYNDROME IDENTIFICATION THROUGH THE IMPLEMENTATION OF ENHANCED TUMOR TESTING AND A COMPREHENSIVE SYSTEMS APPROACH. Gastroenterology 2020, 158: s-1. DOI: 10.1016/s0016-5085(20)30682-x.
- 5 Tissue Sampling, Specimen Handling, and Laboratory ProcessingGibson J, Odze R. 5 Tissue Sampling, Specimen Handling, and Laboratory Processing. 2019, 51-68.e6. DOI: 10.1016/b978-0-323-41509-5.00005-0.
- Autoimmune Enteropathy in an Ulcerative Colitis PatientRodriguez N, Gupta N, Gibson J. Autoimmune Enteropathy in an Ulcerative Colitis Patient. ACG Case Reports Journal 2018, 5: e78. DOI: 10.14309/02075970-201805000-00078.
- Autoimmune Enteropathy in an Ulcerative Colitis PatientRodriguez N, Gupta N, Gibson J. Autoimmune Enteropathy in an Ulcerative Colitis Patient. ACG Case Reports Journal 2018, 5: e781-3. DOI: 10.14309/02075970-201805110-00003.
- Su1706 Confocal LASER Endomicroscopy Features of Sessile Serrated Adenomas/PolypsParikh N, Gibson J, Nagar A, Aslanian H. Su1706 Confocal LASER Endomicroscopy Features of Sessile Serrated Adenomas/Polyps. Gastrointestinal Endoscopy 2015, 81: ab385. DOI: 10.1016/j.gie.2015.03.1555.
- Su1993 Somatic Mutations in the Mismatch Repair System Are Responsible for a Majority of Unexplained Lynch Syndrome Cases: Time to Revise Lynch Syndrome Screening?Xicola R, Carroll T, Emmadi R, Alagiozian-Angelova V, Alvikas J, Marwaha P, Regan M, Gibson J, Mitchell K, Kupfer S, Ellis N, Llor X. Su1993 Somatic Mutations in the Mismatch Repair System Are Responsible for a Majority of Unexplained Lynch Syndrome Cases: Time to Revise Lynch Syndrome Screening? Gastroenterology 2015, 148: s-570. DOI: 10.1016/s0016-5085(15)31922-3.
- Tu1338 Increased Mucosal Mast Cells in Patients With Diarrhea-Predominant IBSChander B, Kinzel J, Hanson J, Ciarleglio M, Gibson J, Deng Y, Jain D. Tu1338 Increased Mucosal Mast Cells in Patients With Diarrhea-Predominant IBS. Gastroenterology 2012, 142: s-806. DOI: 10.1016/s0016-5085(12)63132-1.
- Pathology of Diseases that Cause Upper Gastrointestinal Tract BleedingGibson JA, Odze RD. Pathology of Diseases that Cause Upper Gastrointestinal Tract Bleeding. Gastrointestinal Endoscopy Clinics Of North America 2011, 21: 583-596. PMID: 21944412, DOI: 10.1016/j.giec.2011.07.006.
- MUC Expression in Hyperplastic and Serrated Colonic PolypsGibson JA, Hahn HP, Shahsafaei A, Odze RD. MUC Expression in Hyperplastic and Serrated Colonic Polyps. The American Journal Of Surgical Pathology 2011, 35: 742-749. PMID: 21490447, DOI: 10.1097/pas.0b013e31821537a2.
- Mucosal Schwann Cell “Hamartoma”Gibson JA, Hornick JL. Mucosal Schwann Cell “Hamartoma”. The American Journal Of Surgical Pathology 2009, 33: 781-787. PMID: 19065103, DOI: 10.1097/pas.0b013e31818dd6ca.
- Podoplanin (D2-40) Is a Novel Marker for Follicular Dendritic Cell TumorsYu H, Gibson JA, Pinkus GS, Hornick JL. Podoplanin (D2-40) Is a Novel Marker for Follicular Dendritic Cell Tumors. American Journal Of Clinical Pathology 2007, 128: 776-782. PMID: 17951199, DOI: 10.1309/7p8u659jbjcv6eeu.